Glucose Metabolism, Muscle Mass/Function and Inflammation in the Elderly
NCT ID: NCT02426073
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
76 participants
OBSERVATIONAL
2017-01-31
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diet in Elderly With Type 2 Diabetes
NCT05961878
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
NCT06212778
Sarcopenia and Diabetes Mellitus
NCT04407819
Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus
NCT05585502
Low Density Lipoprotein (LDL) Cholesterol Metabolism in Impaired Glucose Tolerance
NCT01020578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HE
Healthy elderlies
No interventions assigned to this group
DM
Elderlies with type 2 diabetes
No interventions assigned to this group
SA
Elderlies with sarcopenia
No interventions assigned to this group
DS
Elderlies with both type 2 diabetes and sarcopenia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sarcopenia (non-severe): individuals with low muscle mass and either low muscle strength or low physical performance will be diagnosed with sarcopenia, according to the criteria of the European Working Group on Sarcopenia in Older People (EWGSOP)
Exclusion Criteria
* chronic obstructive pulmonary disease (COPD)
* conditions associated with sarcopenia/altered body composition (e.g. disability, altered endocrine function, chronic diseases, nutritional deficiencies, cancer),
* obesity (body mass index ≥30 kg/m2)
* moderate-severe hepatic disease,
* chronic kidney disease (estimated glomerular filtration rate \<30 ml/min per 1.73m2),
* metal prostheses,
* recent or ongoing infection,
* inability or unwillingness to provide informed consent
* type 1 diabetes,
* hemoglobin A1c \>8.5% (69 mmol/mol),
* basal-bolus insulin therapy,
* insulin pump therapy,
* proliferative diabetic retinopathy,
* diabetic foot.
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rome Tor Vergata
OTHER
Fondazione Roma
UNKNOWN
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giaccari Andrea
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catholic University of Sacred Heart
Rome, , Italy
Ospedale San Giovanni Calibita - Fatebenefratelli Isola Tiberina
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5312/15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.